Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. (trading symbol: NAOV) on May 18, 2023. The filing serves as a Regulation FD disclosure regarding a letter to shareholders discussing a review of the first quarter of 2023 and recent business developments. The registrant is incorporated in Delaware and lists its common stock on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a shareholder letter (Exhibit 99.1) containing the review of the first quarter of 2023, but the financial data itself is not included in the body of this 8-K report.
Material Changes
No specific material changes in financial position or operations are detailed in the text of this filing. The report indicates that the Company issued a letter to shareholders to discuss recent business developments and the Q1 2023 review, but the specific nature of these changes is contained within the referenced exhibit.
Guidance, Outlook, and Risks
The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the materials attached. The information is furnished pursuant to Item 7.01 and is not deemed filed for purposes of Section 18 of the Exchange Act, nor is it subject to the liabilities of that section. No forward-looking guidance or specific risk factors are enumerated in this summary text.
Investor Verification Checklist
- Review Exhibit 99.1 (Letter to Shareholders dated May 18, 2023) for specific details on Q1 2023 performance and business developments.
- Verify the current status of the company's cash position and runway, as no liquidity figures are provided in this filing.
- Confirm if the "recent business developments" mentioned in the letter involve strategic pivots, funding rounds, or operational changes.
- Note that this filing is a disclosure of a shareholder communication and does not constitute a formal financial report with audited or reviewed numbers.